Cited by 982Amyotrophic Lateral Sclerosis ResearchGenetic Neurodegenerative DiseasesHereditary Neurological Disorders

The C9orf72 repeat expansion disrupts nucleocytoplasmic transport.

Open access
Zhang, Ke, Donnelly, Christopher J., Haeusler, Aaron R., Grima, Jonathan C., Machamer, James B., Steinwald, Peter, Daley, Elizabeth L., Miller, Sean J. +13 more·2015·Nature

Abstract

The hexanucleotide repeat expansion (HRE) GGGGCC (G4C2) in C9orf72 is the most common cause of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). Recent studies support an HRE RNA gain-of-function mechanism of neurotoxicity, and we previously identified protein interactors for the G4C2 RNA including RanGAP1. A candidate-based genetic screen in Drosophila expressing 30 G4C2 repeats identified RanGAP (Drosophila orthologue of human RanGAP1), a key regulator of nucleocytoplasmic transport, as a potent suppressor of neurodegeneration. Enhancing nuclear import or suppressing nuclear export of proteins also suppresses neurodegeneration. RanGAP physically interacts with HRE RNA and is mislocalized in HRE-expressing flies, neurons from C9orf72 ALS patient-derived induced pluripotent stem cells (iPSC-derived neurons), and in C9orf72 ALS patient brain tissue. Nuclear import is impaired as a result of HRE expression in the fly model and in C9orf72 iPSC-derived neurons, and these deficits are rescued by small molecules and antisense oligonucleotides targeting the HRE G-quadruplexes. Nucleocytoplasmic transport defects may be a fundamental pathway for ALS and FTD that is amenable to pharmacotherapeutic intervention.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/nature14973

Cites

50 of 50 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Disruption of NCC is a well-established effect of aging across species and is directly associated with ALS and FTD.

    “Disruption of NCC is a well-established effect of aging across species and is directly associated with other diseases, including amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD).”

    From Chemically induced reprogramming to reverse cellular aging (2023) · cites this paper as [62]

    The Discussion (page unavailable) links nucleocytoplasmic transport defects to C9ORF72-associated ALS and FTD. It also says nuclear pore integrity is lost during normal aging, but describes a role for pore dysfunction in age-related neurodegeneration as speculative; it does not establish transport disruption as an effect of aging across species. (LLM, conf=0.87)

    Experimental — accuracy not yet measured
  • Disruption of the Ran gradient, mislocalization of nuclear pore components, and disturbance of nuclear pore architecture have likewise been described in ALS/FTLD-TDP samples and disease models.

    “Disruption of the Ran gradient, mislocalization of nuclear pore components, and disturbance of nuclear pore architecture — all of which we observed upon NLK overexpression — have likewise been described in ALS/FTLD-TDP samples and disease models (9–11, 50).”

    From Nemo-like kinase disrupts nuclear import and drives TDP43 mislocalization in ALS (2025) · cites this paper as [10]

    The Results section on the Ran gradient reports a reduced nuclear-to-cytoplasmic Ran ratio in C9-ALS iPS neurons, while the nuclear-pore-pathology Results and Extended Data describe abnormal RanGAP1, Nup205, and Nup107 localization in C9-ALS patient tissue and models. The paper does not establish a disturbance of nuclear pore architecture as distinct from component pathology, or document all three findings across ALS/FTLD-TDP samples and models generally. (LLM, conf=0.86)

    Experimental — accuracy not yet measured
  • Genetic screens in ALS model systems have repeatedly uncovered nuclear pore and nucleocytoplasmic transport factors as potent disease modifiers.

    “Genetic screens in ALS model systems have repeatedly uncovered nuclear pore and nucleocytoplasmic transport factors as potent disease modifiers, confirming the significance of these pathways in disease pathogenesis (9–11).”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Zhang, K., Donnelly, C. J., Haeusler, A. R., Grima, J. C., Machamer, J. B., Steinwald, P., Daley, E. L., Miller, S. J., Cunningham, K. M., Vidensky, S., Gupta, S., Thomas, M. A., Hong, I., Chiu, S.-L., Huganir, R. L., Ostrow, L. W., Matunis, M. J., Wang, J., Sattler, R., Lloyd, T. E., & Rothstein, J. D.
Affiliations
Johns Hopkins University (US)
Corresponding author
  • Lloyd, Thomas E.
  • Rothstein, Jeffrey D.
Venue
Nature
Published
2015-08-26
Volume
525
Issue
7567
Pages
56-61
ISSN
  • 0028-0836 (ISSN-L)
  • 1476-4687
OpenAlex
W1797572428
Cited by
982
References
50
Citations by year
2026: 40 · 2025: 56 · 2024: 74 · 2023: 74 · 2022: 71 · 2021: 130 · 2020: 113 · 2019: 92 · 2018: 110 · 2017: 98 · 2016: 102 · 2015: 22
FWCI
77.72
Type
journal article
Language
en
Open access
Locations
  • Nature (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
  • RePEc: Research Papers in Economics (submittedVersion)
Funders
  • National Institutes of Health (P40OD018537)
  • National Institute on Aging (P01AG012992)
  • National Cancer Institute (CA009110, T32CA009110)
  • National Institute of General Medical Sciences (R01GM084947, R01GM060980)
  • National Institute of Neurological Disorders and Stroke (R00NS091486, R01NS085207, NS089616, U54NS091046, K99NS091486, NS091046, RC2NS069395, U24NS078736, R01NS082563, R01NS094239, R01NS074324, R01NS089616)
Topics
  • Health Sciences › Medicine › Neurology › Amyotrophic Lateral Sclerosis Research
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Genetic Neurodegenerative Diseases
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Hereditary Neurological Disorders
Keywords
C9orf72, G4C2 repeat expansion, hexanucleotide repeat expansion, amyotrophic lateral sclerosis, frontotemporal dementia, RanGAP1, RanGAP, nuclear transport, nuclear import, nuclear export, G-quadruplex, antisense oligonucleotides, small molecules, neurodegeneration
MeSH terms
C9orf72 Protein, Amyotrophic Lateral Sclerosis, Animals, Brain, Cell Nucleus, Drosophila melanogaster, Female, Humans, Neurons, Nuclear Proteins, Proteins, RNA, Open Reading Frames, Oligonucleotides, Antisense, GTPase-Activating Proteins, Active Transport, Cell Nucleus, Nuclear Pore, Drosophila Proteins, DNA Repeat Expansion, G-Quadruplexes, Induced Pluripotent Stem Cells, Frontotemporal Dementia

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review